Table 1.
Clinical information for intrahepatic cholangiocarcinoma patients
| Variables | N=173 | |
|---|---|---|
| Age (years) | Mean ± SD | 58.83±11.31 |
| Gender | Male | 107 (38.2) |
| Female | 66 (61.8) | |
| Stage | Locally advanced | 36 (20.8) |
| Metastatic | 137 (79.2) | |
| CA19-9 | <1,000 IU/mL | 109 (63.0) |
| ≥1,000 IU/mL | 64 (37.0) | |
| ALB level | Median (range) | 40.7 (26–50.9) |
| GELO level | Median (range) | 29.9 (20.9–55) |
| TP level | Median (range) | 71.9 (53.3–89.3) |
| ALP level | Median (range) | 138 (51.4–1,500) |
| ALT level | Median (range) | 26.6 (5.0–545.30) |
| AST level | Median (range) | 32.6 (10–366.2) |
| TBIL level | Median (range) | 12.2 (4.3–421.3) |
| DBIL level | Median (range) | 4.7 (0.8–322.8) |
| GGT level | Median (range) | 113 (11–2,064) |
| LDH level | Median (range) | 192 (74–833) |
Abbreviations: ALB, albumin; ALP, alkaline phosphatase; TBIL, total bilirubin; DBIL, direct bilirubin; GGT, gamma glutamyltranspeptidase; GELO, globulin; TP, total protein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; SD, standard deviation.